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Background: T cells and natural killer (NK) cells perform complementary roles
in the cellular immune system. T cells identify infected cells directly through
recognition of antigenic peptides that are displayed at the target cell surface by
the classical major histocompatibility complex (MHC) class I molecules. NK
cells monitor the target cell surface for malfunction of this display system, lysing
potentially infected cells that might otherwise evade recognition by the T cells.
Human killer cell inhibitory receptors (KIRs) control this process by either
inhibiting or activating the cytotoxic activity of NK cells via specific binding to
MHC class I molecules on the target cell.
Results: We report the crystal structure of the extracellular region of the human
p58 KIR (KIR2DL3), which is specific for the human MHC class I molecule
HLA-Cw3 and related alleles. The structure shows the predicted topology of
two tandem immunoglobulin-like domains, but comparison with the previously
reported structure of the related receptor KIR2DL1 reveals an unexpected
change of 23° in the relative orientation of these domains.
Conclusions: The altered orientation of the immunoglobulin-like domains
maintains an unusually acute interdomain elbow angle, which therefore appears
to be a distinctive feature of the KIRs. The putative MHC class I binding site is
located on the outer surface of the elbow, spanning both domains. The
unexpected observation that this binding site can be modulated by differences
in the relative domain orientations has implications for the general mechanism of
KIR–MHC class I complex formation.
Introduction
The human natural killer (NK) cells are a class of lym-
phocytes that kill certain virus-infected or tumour cells
and are involved in innate immunity against viruses,
intracellular bacteria and parasites. These activities com-
plement the actions of the cytotoxic T cells, providing a
robust cellular immune system. Several cell-surface
receptors have recently been implicated in the control of
NK-cell-mediated cytotoxicity (reviewed in [1–3]). Two
types of receptors on human NK cells have been identi-
fied: c-type lectin receptors and immunoglobulin super-
family (IgSF) receptors. The IgSF-type receptors, termed
the killer cell inhibitory receptors (KIRs) or natural killer
cell inhibitory receptors (NKIRs), function by specific
recognition of classical major histocompatibility complex
(MHC) class I molecules (in humans the human leuco-
cyte antigen HLA-A, HLA-B and HLA-C alleles) on the
target cell surface [4–6]. The absence of classical MHC
class I molecules is by default taken as an indication that
the target cell is abnormal and should be lysed by the NK
cell. Members of the KIR family of receptors inhibit such
lysis on detecting the presence of a standard set of MHC
class I molecules on the target cell.
The receptors of the KIR family can be grouped according
to whether their extracellular regions comprise two
immunoglobulin (Ig) domains (p58 KIRs) or three Ig
domains (p70 KIRs) [7]. The two-Ig-domain receptors
(KIR2DL1, 2 and 3) bind specific HLA-C alleles, and the
three-Ig domain receptors (KIR3DL1 and 2) recognise
certain of the HLA-A and B alleles. These KIRs are very
similar to each other, with over 80% sequence identity
between equivalent domains (Figure 1). The binding site
of the p58 KIRs on the MHC class I molecule has been
mapped to residues 73, 76, 80 and 90, located on the 
C-terminal part of the α1 helix in the MHC class I heavy
chain [8,9]. KIR2DL1 and KIR2DL3 discriminate
between alleles bearing lysine (HLA-Cw4-related) or
asparagine (HLA-Cw3-related) at MHC residue 80 and
exhibit some limited, peptide-dependent specificity
[10,11]. Residues 44, 45, 70 and 183 in the p58 KIRs
([12–15]; H Reyburn, personal communication) have been
implicated as the cognate determinants of MHC class I
binding. Structural studies on the KIRs and their com-
plexes with MHC class I molecules should clarify the role
of these residues and the structural basis of these specific
recognition and signalling interactions.
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In 1996, Fan et al. [16] demonstrated that a soluble recom-
binant version of KIR2DL1 (consisting of the entire extra-
cellular region, residues 1–224, produced in Escherichia coli
and refolded) can specifically bind recombinant HLA-Cw4.
A truncated form of this region (residues 1–200, produced
by similar means) also showed specific binding and was
used for crystallographic structure determination [17]. We
report in this study the crystal structure of the extracellular
region of KIR2DL3 (NKAT2), the p58 KIR specific for the
group of HLA-Cw3-related alleles (including HLA-Cw1,
HLA-Cw3 and HLA-Cw7). Comparison of the current
KIR2DL3 structure with the structure of KIR2DL1 deter-
mined by Fan et al. [17] defines the generic characteristics
of this family of receptors and allows the determinants of
the allele-specific binding to be assessed.
Results and discussion
Structure of KIR2DL3
The structure of KIR2DL3 residues 1–224 was deter-
mined by molecular replacement for crystals containing
one molecule per asymmetric unit. The atomic model has
been satisfactorily refined, despite the limited resolution
of the diffraction data (nominally 3 Å; Table 1), to a final
R factor of 24.8% (Rfree 32.0%). The extracellular region of
KIR2DL3 has two tandem Ig-like domains (Figure 2) as
predicted from the amino acid sequence analysis. The
individual Ig-like domain structures of KIR2DL3 are very
similar to those of KIR2DL1 with a root mean square
(rms) difference between KIR2DL1 and KIR2DL3 of
0.92 Å for 95 equivalent Cα atoms in the N-terminal
domain (D1) and 0.80 Å for 97 Cα atoms of the C-terminal
domain (D2). The topologies of the two domains of
KIR2DL3 are essentially identical, with a β sheet of three
antiparallel strands (A, B and E) and one short extra strand
(D-like) packed against a β sheet of four antiparallel
strands (C′CFG) with one extra A′ strand (Figures 1
and 2a). As in KIR2DL1, the switch from strand A to
strand A′ is marked by a cis-proline residue (Pro14 in D1 or
Pro114 in D2). The region around the D-like strand in 
D2 (residues 153–157) appears flexible, showing weak
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Figure 1
Amino acid sequence alignment of the
extracellular regions of KIR family members.
Each KIR family member shows different
ligand specificity [7]. KIR3DL1 and KIR3DL2
contain an additional N-terminal Ig-like domain
that is omitted from the alignment. The residue
numbering and secondary structure for
KIR2DL3 are indicated above the alignment.
Symbols below the alignment mark putative
MHC class I binding site residues (solid
arrowheads), residues contributing to the
hydrophobic surface in the vicinity of the
putative binding site (crosses) and a potential
determinant of domain–domain orientation
(solid circles). This figure was produced using
the program ESPript (P Gouet, F Courcelle, D
Stuart and F Metoz, unpublished data). 
                                                            
1        10        20        30        40        50        60
KIR2DL3(NKAT2) H  V                E                L     KFK T H    H      EG HRKPSLLAHPGPLVKS ETVILQCWSDVRFQHF LHREG   D L LIGE HDGVS
KIR2DL1(NKAT1) H  V                E                L     MFN T R    H      EG HRKPSLLAHPGPLVKS ETVILQCWSDVMFEHF LHREG   D L LIGE HDGVS
KIR3DL1(NKAT3) V  N                G                F     ISK P R    I      TG HRKPSLLAHPGPLVKS ERVILQCWSDIMFEHF LHKEG   D S LVGQ HDGVS
KIR3DL2(NKAT4) V  N                G                F     ISE P R    I      TG HRKPSLLAHPGPLLKS ETVILQCWSDVMFEHF LHREG   D S LVGQ HDGVS
                                                            
         70        80        90       100       110       120
KIR2DL3(NKAT2)       GP MQD           T                   L              L KANFSI  M   LAGTYRCYGSV HSPYQLSAPSDPLDIVITG YEKPSLSAQPGPTV A
KIR2DL1(NKAT1)       SR TQD           T                   L              L KANFSI  M   LAGTYRCYGSV HSPYQVSAPSDPLDIVIIG YEKPSLSAQPGPTV A
KIR3DL1(NKAT3)       GP MLA           T                   P              Q KANFSI  M   LAGTYRCYGSV HTPYQLSAPSDPLDIVVTG YEKPSLSAQPGPKV A
KIR3DL2(NKAT4)       GP MPV           P                   L              Q KANFSI  L   LAGTYRCYGSV HSPYQLSAPSDPLDIVITG YEKPSLSAQPGPTV A
                                            +               
                                                            
        130       140       150       160       170       180
KIR2DL3(NKAT2)           R            E      S GP   G                      GESVTLSCSS SSYDMYHLSREG AHERRF A  KVN TFQADFPLGPATHGGTYRCFGS
KIR2DL1(NKAT1)           R            E      P GP   G                      GENVTLSCSS SSYDMYHLSREG AHERRL A  KVN TFQADFPLGPATHGGTYRCFGS
KIR3DL1(NKAT3)           R            G      P VR   R                      GESVTLSCSS SSYDMYHLSREG AHERRL A  KVN TFQADFPLGPATHGGTYRCFGS
KIR3DL2(NKAT4)           W            E      R VP   R                      GENVTLSCSS SSYDIYHLSREG AHERRL A  KVN TFQADFPLGPATHGGTYRCFGS
                                                            
        190       200       210       220                   
KIR2DL3(NKAT2)  RD  Y   NS                            P                    F  SP EWS  SDPLLVSVTGNPSNSWPSPTEPSSETGN RHLH
KIR2DL1(NKAT1)  HD  Y   KS                            P                    F  SP EWS  SDPLLVSVTGNPSNSWPSPTEPSSKTGN RHLH
KIR3DL1(NKAT3)  RH  Y   DP                            P                    F  SP EWS  SDPLLVSVTGNPSSSWPSPTEPSSKSGN RHLH
KIR3DL2(NKAT4)  RA  C   NS                            C                    F  LP VWS  SDPLLVSVTGNPSSSWPSPTEPSSKSGI RHLH
+                                                           
Α A′ B C C′ D 
E F G A A′




Data collection and refinement statistics of KIR2DL3.
Space group P6522
Cell parameters (Å) a = b = 95.4, c = 130.8
Data processing
Observations to 3.0 Å (F>0) 18,460
Unique reflections 6281
Completeness (%) 84.9 (87.6)*
Rmerge (%) 19.5 (49.0)*
I/σ(I) 4.7 (1.5)*
Refinement 
Data range (Å) 15.0–3.0
Reflections (F>0) 5896
Completeness (%) 79.4
Rms deviations from target geometry
bond lengths (Å) 0.008
bond angles (°) 1.57
∆B bonded mainchain atoms (Å2) 2.0
∆B angle related mainchain atoms (Å2) 3.4
Rfree (%)† 32.0
Rcryst (%)‡ 24.8
*Values for the highest resolution shell (3.11–3.0 Å).
†Rcryst = Σ | |Fobs|–|Fcalc| | / Σ |Fobs|. ‡Rfree is as for Rcryst but calculated
for a test set comprising reflections not used in the refinement (5%).
electron density in the KIR2DL3 maps, but clearly adopt-
ing a different conformation to that seen in KIR2DL1
(which lacks a D-like strand in D2). As in the KIR2DL1
structure, the N-terminal four residues in KIR2DL3 are
not an integral part of D1 and are disordered in the crystal
structure. The soluble form of  KIR2DL3, which was crys-
tallised, corresponds to the full extracellular region, that is,
it contains an additional 24 C-terminal residues that are
not present in the KIR2DL1 construct (truncated at
residue 200). Of these additional residues, only 201–203
could be fitted into clear electron density; the remainder
of this region, in common with the N terminus, appears to
be highly flexible. The inclusion of residues 201–224 in
the soluble KIR2DL1 construct has been reported to
enhance MHC class I binding [17]. In the KIR2DL3 crys-
tals, residues 201–203 mediate a crystal lattice contact
with residues in the ABE β sheet of D1. Neither this
interaction, nor any of the other lattice contacts, have any
apparent biological relevance. We cannot therefore
provide an explanation for the reported effect of residues
201–224 on MHC class I binding.
Structural comparisons with IgSF and haematopoietic
receptors
In 1997 Fan et al. classified the domains of the KIRs as a
distinct subtype of the Ig-like fold with features resem-
bling the fibronectin type III (FNIII)-like folds of the
haematopoietic receptor family. The coordinates for D1
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Figure 2
Schematic of the KIR2DL3 structure. (a) Sidechains are shown in ball-
and-stick representation for the putative binding site (indicated by the
arrow; residues 44, 45, 70 and 183, yellow) and the WSXWS-like box
in D2 (residues 188–192, grey). This figure was produced using the
programs BOBSCRIPT [41] and Raster3D [42]. (b) Cα trace of
KIR2DL3. Every tenth amino acid residue is numbered. (c,d) Stereo
comparisons of the KIR2DL3 domain with other domains. Cα traces
showing pairwise superpositions of KIR2DL3 (D2, red) with (c) hGHR
(D2, blue) and (d) ICAM2 (D2, green). 
and D2 of KIR2DL3 when submitted to the structure sim-
ilarity search program DALI (version 2.0) [18] registered
closest similarity to the domains of monomeric IgSF cell
adhesion molecules of the integrin-binding family — inter-
cellular adhesion molecule 2 (ICAM2) [19] and vascular
cell adhesion molecule 1 (VCAM1) [20,21]; ICAM2 gave
an rms deviation of 2.6 (2.3) Å for 88 (89) equivalent Cα
atoms in D2 (D1). The match to examples of the FNIII-
type fold was less close; for example, human growth
hormone receptor (hGHR) [22] gave an rms deviation of
2.4 (2.5) Å for 82 (81) equivalent Cα atoms in D2 (D1).
Structural superpositions (Figure 2c,d) reveal that the
source of this difference is the relative packing of the β
sheets. The core of the KIR domain contains key residues
of the classic IgSF motif structure (for example in D1
residues Cys28, Tyr77 and Cys79) and lacks the character-
istic residues of the FNIII family hydrophobic core [23].
This results in a basic KIR domain architecture that is con-
sistent with an evolutionary relationship to the IgSF cell
adhesion molecules.
As noted by Fan et al. [17], however, certain structural fea-
tures that were previously specific to the FNIII-domain-
based structures of the haematopoietic receptors are
present in the KIR2DL1 structure and these features are
conserved in KIR2DL3. Both D1 and D2 have a region at
the N terminus of strand G (residues 90–94, LSAPS [single-
letter amino acid code], in D1 or 188–192, WSNSS [single-
letter amino acid code], in D2) that is similar to the WSxWS
box, a signature sequence motif of the class I haemato-
poietic receptors (e.g., hGHR [22], human erythropoietin
receptor (EPOR) [24], human prolactin receptor (hPLR)
[25] and gp130 [26]) (Figure 2a). In both domains of
KIR2DL3, the mainchain structure conforms to the double
β bulge conformation of the classic WSxWS box. The
extended pi-cation system, involving stacking of the trypto-
phan residues in the hematopoietic receptors is, however,
absent in the KIRs (the sidechain of Trp188 in D2 partici-
pates in the interdomain interactions, see below).
The D1–D2 interface and relative domain–domain
orientation
The relative orientation of the two domains in KIR2DL3
can, in part, be specified in terms of the ‘elbow’ angle —
the angle between the major axes of the domains. The
elbow angle in the crystal structure of KIR2DL3 is about
70°, which is similar to the elbow angle of approximately
60° in the KIR2DL1 structure (Figure 3a). This acute
angle appears to be a distinguishing feature of the KIRs.
As noted by Fan et al. [17], it is more closely related to the
angles of approximately 90° reported for the class I
haematopoietic receptors, hGHR [22], EPOR [24] and
gp130 [26] than the values of about 135° observed in other
IgSF cell-surface receptors [21]. The structural determi-
nants of the linker and D1–D2 interface in the KIRs are,
however, distinct from those in the haematopoietic recep-
tors. Two aromatic residues (Tyr134 and Trp188), con-
served in the KIRs (Figure 1), appear to make key
contributions to the formation of the acute elbow angle.
Of these, Trp188 is part of the WSXWS-like box in D2
but is tucked into the D1–D2 interface and Tyr134 medi-
ates a hydrogen bond to the mainchain carbonyl atom of
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Figure 3
Comparison of KIR2DL3 and KIR2DL1 structures. (a) Comparison of
the D1–D2 orientation in KIR2DL3 (red) and KIR2DL1 (green). Cα
traces for superposition based on D2 are shown in two orthogonal
views. (b) Comparison of the D1–D2 interface in KIR2DL3 (grey with
sidechain atoms coloured orange, blue and red for C, N and O,
respectively) and KIR2DL1 (green). Key residue sidechains are shown
in ball-and-stick representation. The mauve mesh depicts the sidechain
electron density for residues 17, 100, 102, 178 and 188, for which the
sidechain atoms beyond Cα were omitted from the phasing model
(2Fo–Fc map contoured at 1σ).
residue 106 in the linker. Overall, the interdomain interac-
tions of both KIR2DL3 and KIR2DL1 are primarily
hydrophobic and the total solvent accessible area buried at
the interface is very similar in the two structures (1050 Å2
and 1060 Å2 for KIR2DL3 and KIR2DL1, respectively).
Unexpectedly, however, despite this degree of conserva-
tion, there is a significant difference in the overall inter-
domain orientation between KIR2DL3 and KIR2DL1.
Comparison of the KIR2DL3 and KIR2DL1 crystal struc-
tures reveals a difference in the relative domain–domain
orientation of 23°, arising primarily from a twist in the D1
position relative to the D2 major axis (Figure 3a). This
observation implies either that there is a true difference in
D1–D2 orientation between the KIRs or that there is a
substantial flexibility in the KIR linker region, such that
the domain orientations observed in the current structures
have been selected from an allowed range by the lattice
contacts in the crystals. Domain–domain flexion has been
observed in several IgSF receptors, such as CD2 [27], but
has been associated with less substantial interfaces, for
example an interface of 700 Å2 in CD2. The 1050 Å2 of
buried surface in the KIR-type interface appears more
comparable to the rigid interface between domains 1 and 2
of CD4 (980 Å2 of buried surface area) [28,29]. The inter-
domain linker regions of the class I hematopoietic recep-
tors also appear to be relatively rigid [26], although Muller
et al. [30] recently observed a flexion of about 13° in the
domain–domain orientation of tissue factor, a class II
haematopoietic receptor. The magnitude of the change
between KIR2DL3 and KIR2DL1 does, however, tend to
argue for at least some degree of distinct difference in the
domain–domain orientation of these two KIRs that is
independent of any inherent flexibility.
There are only two residue differences, isoleucine to thre-
onine at residue 102 and lysine to asparagine at residue
190 (in KIR2DL1 and KIR2DL3, respectively), that could
cause the altered domain–domain orientation. Of these,
the Ile102→Thr change is most central to the interface
and clearly necessitates alterations in the hydrophobic
core (Figure 3b). With the exception of the loss of one
hydrogen bond (Pro96(O)–His146(NE2)) in KIR2DL3,
equivalent residues contribute to the D1–D2 interface in
both KIRs and the altered orientation is accommodated by
a relatively subtle repacking of the interface. One example
of this repacking is a change in the conformation of
Tyr186 and Glu187 in the FG loop of D2 that allows the
hydrogen-bonding network to Thr76 and Asn71 in D1 to
be maintained. These subtle local changes, and the resul-
tant differences in domain–domain arrangement between
KIR structures, may have functional implications.
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Figure 4
MHC class I binding site of KIR2DL3. (a) Comparison of the putative
binding site for MHC class I on KIR2DL3 (grey with sidechain atoms
coloured orange, blue and red for C, N and O, respectively) and
KIR2DL1 (green). Key residue sidechains are shown in ball-and-stick
representation. (b) Hydrophobic analysis (using a version of the
program GRID, P Goodford unpublished, with graphical output by M
Noble) of the protein surface of KIR2DL3. Hydrophobic areas at the
surfaces are highlighted in red. The view (along the arrow indicated in
Figure 2a) is onto the elbow region. Two strongly hydrophobic regions
lie in the vicinity of the putative MHC class I binding site, one comprises
Lys44 and Phe45 and the other is formed by Tyr105 and Phe181. The
overall analysis reveals a greater number of hydrophobic regions in D1.
One such region arises from Tyr80 and Tyr88. These residues are
structurally equivalent to Tyr178 and Trp188 in D2, residues that
contribute to the D1–D2 interface. Given that these residues are
conserved in the sequences of the three-Ig-domain KIRs (Figure 1),
they may contribute to a similar interface between D1 and the additional
Ig-like domain (D0) that is present at the N terminus of these molecules.
The nature of the putative binding site for MHC class I
Site-directed mutagenesis and sequence comparisons
between KIRs have implicated residues 44 and 45 on the
CC′ loop of D1, residues 70–72 on the EF loop of D1 and
residue 183 on the FG loop of D2 in MHC class I binding
([12–15]; H Reyburn, personal communication). These data
mapped the putative binding site to the outer surface of the
D1–D2 elbow in KIR2DL1, the equivalent region to that
used for ligand binding in the haematopoietic receptors [17]
(Figure 2a). The conservation of the distinctive elbow angle
in KIR2DL3 further strengthens the arguments for the
functional significance of this region. Conversely, the differ-
ences in this surface now observed between the KIR2DL3
and KIR2DL1 structures are of direct relevance to the
allospecificity of binding shown by these KIRs.
The putative MHC class I binding sites of KIR2DL3 and
KIR2DL1 are compared in Figure 4a. The substitution of
lysine at residue 44 in KIR2DL3 (in place of methionine
in KIR2DL1) has little effect on the structure of the CC′
loop, but the sidechain conformations of Lys44 and Phe45
are slightly changed by a shift in the position of the EF
loop towards the CC′ loop, which appears to arise from 
the substitution of Arg68 (KIR2DL1) with proline
(KIR2DL3). This substitution produces changes in the
mainchain conformation around residue 68 that are trans-
mitted to the D1 hydrophobic core via a reorientation of
the phenolic group of Phe64 and therefore, indirectly,
alters the putative binding site structure around residues
70–72 on the EF loop and residues 44 and 45 on the CC′
loop. Such changes, propagated from residue 68, are likely
to contribute to the effect on binding affinity observed on
swapping residues 67–70 (G67PMM70, KIR2DL3, with
S67RMT70, KIR2DL1) [12].
The sidechain Nε of Lys44 makes a hydrogen bond to the
mainchain carboxyl O of Gln71, so the addition of this
positively charged residue does not greatly impact on the
hydrophobic nature of this region. The hydrophobic
potential analysis (using a version of the program GRID, P
Goodford unpublished, with graphical output by M
Noble) of KIR2DL3 clearly shows a strongly hydrophobic
surface contributed from the exposed aromatic groups of
Phe45, Phe181 and Tyr105 as well as the hydrophobic
portion of the Lys44 sidechain (Figure 4b). In the
haematopoietic receptors, and indeed generally in
protein–protein recognition, hydrophobic interactions are
crucial to ligand binding [31]. This analysis is therefore
suggestive of the involvement of these residues in MHC
class I binding.
Biological implications
The nature and mode of action of the cell-surface recep-
tors that control the function of natural killer (NK) cells
are currently a major focus of research in immunology.
Killer cell inhibitory receptors (KIRs) have been identified
as key elements in the inhibition of NK cell cytotoxicity.
The inhibitory signal is generated in response to the
recognition of specific major histocompatibility complex
(MHC) class I molecules on the surface of the target cell
by one or more of a variety of KIRs on the NK cell. The
structure of KIR2DL3, detailed here, in conjunction with
the previously reported structure of KIR2DL1, provide
the first insights into the structural basis for this novel
form of MHC class I recognition. KIR2DL1 (specific for
HLA-Cw2, HLA-Cw4 and HLA-Cw5 where HLA
stands for human leucocyte antigen) and KIR2DL3 (spe-
cific for HLA-Cw1, HLA-Cw3 and HLA-Cw7) share
93% sequence identity and consist of two immunoglobulin
domains, both of which are thought to contribute to MHC
class I binding ([11–15] H Reyburn, personal communi-
cation). To date, the interpretation of data on the specifici-
ties of these molecules has assumed that the differences
arise solely from the direct effect of residues in the MHC
class I binding site. The current study reveals a more
complex picture.
In summary, the comparison of KIR2DL3 with
KIR2DL1 reveals two types of conformational differ-
ences that might contribute to the altered biological prop-
erties of the molecules. Firstly, there are conformational
changes located to one domain that exert both direct and
indirect effects on the putative MHC class I binding site.
Secondly, there are differences in the relative disposition
of domains 1 and 2 between the two molecules. This
raises the issue of whether the molecules have different
preferred interdomain orientations that may modulate
their specificity or whether, on binding MHC, both mol-
ecules can equally well adopt the same relative orienta-
tion. The latter would imply that the deviation observed
between the crystal structures simply reflects some limited
flexibility inherent to the KIR D1–D2 interface. This may
be crucial to the general mechanism of KIR–MHC class I
complex formation. Further experiments may now be
designed to distinguish between these possibilities.
Materials and methods
Expression and purification of KIR2DL3
Plasmid pGEM2 (Promega) was used as an expression vector for the
production of a soluble form of KIR2DL3 [32]. The extracellular region
of KIR2DL3 (residues 1–224) with a c-Myc linker and histidine6-tag at
the C terminus was expressed and secreted under the control of a T7
promoter using E. coli strain BL21(DE3)pLysS (Novagen). The recom-
binant protein was purified by chelate affinity chromatography (Ni-NTA
superflow, Quiagen) followed by ion exchange chromatography
(MonoQ, Pharmacia). Specific binding to HLA-Cw0702 was verified
using surface plasmon resonance (BIAcore) in collaboration with A van
der Merwe (unpublished observations).
Crystallisation and data collection
Small crystals (maximum size 0.05 × 0.05 × 0.25 mm) were obtained
from 8 µl drops by the sitting drop vapour diffusion method using micro-
bridges [33] in Linbro tissue culture plates at 21°C. A 5 mg/ml protein
solution 20 mM Tris, pH 8.0, was mixed in a 1:1 ratio with the crystallisa-
tion reservoir solution (9–10% PEG8000, 50 mM HEPES, 8% ethylene
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glycol, 0.5% octyl-β-glucoside, pH 7.5) [32]. The crystals belonged to
the space group P6522, with unit-cell dimensions of a = b = 95.4 Å,
c = 130.8 Å and contained one KIR2DL3 molecule per asymmetric unit.
A diffraction data set was collected at 288K, from the single largest
crystal, at station BL-6A of the Photon Factory Synchrotron Radiation
source (Tsukuba, Japan; λ = 1.0 Å) utilising the Weissenberg Camera
[34] and a Fuji imaging plate system (BA100). The diffraction data
were autoindexed and integrated with the program DENZO, then
scaled and merged in the program SCALEPACK [35] (Table 1).
Structure determination and refinement
The structure was determined by molecular replacement using the com-
bined molecular replacement program [36], after a considerable
number of unsuccessful trials using various programs and search
probes. The successful search probes consisted of the individual D1
and D2 domains of KIR2DL1 (coordinates kindly provided by Fan and
Wiley, Harvard). Clear solutions for each Ig-like domain were found in
space group P6522 using Es (normalised structure factors) in the range
10–4.0 Å and the fast rotation function, followed by a translation search
(no significant solutions were found in the enantiomorphic space
group). The correlation coefficients for the correct solutions were 0.23
and 0.26 for D1 and D2, respectively, after determination of both orien-
tation and translation parameters. These correlation coefficients were
1.5 times higher than the next highest peak in each case. The correct-
ness of these solutions was further substantiated by the observation
that application of an appropriate crystallographic symmetry operator to
one domain allowed the complete molecule to be built with a discrep-
ancy of only a few Å for the abutting residues. Two-domain rigid-body
adjustment of the assembled molecules with X-PLOR [37] reduced
Rcryst to 40.0% (Rfree = 45.4%) for all data between 10.0 and 3.0 Å. 
Further refinement was carried out with standard protocols in the pro-
grams X-PLOR, Refmac [38] and CNS [39], and was alternated with
manual rebuilding in the interactive graphics program O [40]. In the
final stage, restrained individual B factors were refined. Refinement sta-
tistics are given in Table 1. The final model comprises residues 5–203
of KIR2DL3 and shows 97.0% of residues in allowed regions of the
Ramachandran plot. 53 residues at the C terminus of the construct
(residues 204–224 of KIR2DL3 plus the c-Myc linker and Histidine6-
tag) could not be located.
Accession numbers
Atomic coordinates for KIR2DL3 have been deposited with the Protein
Data Bank, Brookhaven National Laboratory with the accession code 1b6u.
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